Repetitive low dose oral methotrexate and intravenous mercaptopurine treatment for patients with lower risk B—lineage acute lymphoblastic leukemia. A pediatric oncology group pilot study
Mahoney, Donald H., Camitta, Bruce M., Leventhal, Brigid G., Shuster, Jonathan J., Civin, Curt J., Ganick, Dorothy J., Lauer, Stephen J., Steuber, C. Philip, Kamen, Barton A.
Published in Cancer (15.05.1995)
Published in Cancer (15.05.1995)
Get full text
Journal Article
Conference Proceeding